Dr. Watson at ARTC is the world’s leading investigator for the Lecanemab compound. On September 27, 2022 Eisai Co.,LTD and Biogen Inc. released the following statement.
A Breakthrough in Alzheimer’s Disease.
In the News
Alzheimer’s Research and Treatment Center